BeyondSpring Inc. - 8-K Filing

BeyondSpring completed the sale of its subsidiary BeyondSpring Ltd. to Biolin Investment Limited in exchange for noncash consideration tied to a clinical trial collaboration. (Items: 2.01 Completion of Acquisition or Disposition of Assets, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $BYSI

Read the full article at SEC EDGAR

More Regulatory news